Previous close | 19.71 |
Open | 19.94 |
Bid | 19.12 x 1800 |
Ask | 20.25 x 900 |
Day's range | 19.34 - 19.94 |
52-week range | 17.24 - 26.56 |
Volume | |
Avg. volume | 244,716 |
Market cap | 903.389M |
Beta (5Y monthly) | 0.96 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2024 financial results.
Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.
In direct response to the Nurse Assist, LLC voluntary recall of pre-filled syringes and other sterile water products, Avanos Medical, Inc. (NYSE: AVNS) voluntarily recalled specific lots of MIC* Gastric – Jejunal Feeding Tube Kits on Jan. 16, 2024. These kits include Nurse Assist supplied syringes, pre-filled with sterile water, essential for inflating the retention balloon of the feeding tube.